The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: Outside-in signaling and relationship to tumor progression
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Bhoopathi, P., Chetty, C., Kunigal, S., Vanamala, S. K., Rao, J. S., & Lakka, S. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707931200 · Cited by 55
RetractedMantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Yu, Q., & Stamenkovic, I. (2000) · PubMed · Cited by 1,995
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754
Heissig, B., Hattori, K., Dias, S., Friedrich, M., Ferris, B., Hackett, N. R., Crystal, R. G., Besmer, P., Lyden, D., Moore, M. A. S., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00754-7 · Cited by 1,751
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Gialeli, C., Theocharis, A. D., & Karamanos, N. K. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07919.x · Cited by 1,607
Brooks, P. C., Strömblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P., & Cheresh, D. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81235-0 · Cited by 1,552
Brew, K., & Nagase, H. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.01.003 · Cited by 1,381
Strategies for MMP inhibition in cancer: innovations for the post-trial era
Overall, C. M., & López-Otín, C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc884 · Cited by 1,349
Induction of Cell Migration by Matrix Metalloprotease-2 Cleavage of Laminin-5
Giannelli, G., Falk-Marzillier, J., Schiraldi, O., Stetler-Stevenson, W. G., & Quaranta, V. (1997) · Science · doi:10.1126/science.277.5323.225 · Cited by 1,221
Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
Overall, C. M., & Kleifeld, O. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1821 · Cited by 1,214
Yang, L., DeBusk, L. M., Fukuda, K., Fingleton, B., Green-Jarvis, B., Shyr, Y., Matrisian, L. M., Carbone, D. P., & Lin, P. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.031 · Cited by 1,140
Du, R., Lu, K. V., Petritsch, C., Liu, P., Ganss, R., Passegué, E., Song, H., VandenBerg, S., Johnson, R. S., Werb, Z., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.034 · Cited by 1,130
Matrix Metalloproteinases As Novel Biomarker s and Potential Therapeutic Targets in Human Cancer
Roy, R., Yang, J., & Moses, M. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.5556 · Cited by 854
Physiology and pathophysiology of matrix metalloproteases
Klein, T., & Bischoff, R. (2011) · Amino Acids · doi:10.1007/s00726-010-0689-x · Cited by 828
Emerging roles of proteases in tumour suppression
López-Otín, C., & Matrisian, L. M. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2228 · Cited by 802
Inflammation Dampened by Gelatinase A Cleavage of Monocyte Chemoattractant Protein-3
McQuibban, G. A., Gong, J.-H., Tam, E. M., McCulloch, C. A. G., Clark-Lewis, I., & Overall, C. M. (2000) · Science · doi:10.1126/science.289.5482.1202 · Cited by 772
Tetracyclines: Nonantibiotic properties and their clinical implications
Sapadin, A. N., & Fleischmajer, R. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.10.004 · Cited by 768
Progress in matrix metalloproteinase research
MURPHY, G., & NAGASE, H. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.05.002 · Cited by 759
Oh, J., Takahashi, R., Kondo, S., Mizoguchi, A., Adachi, E., Sasahara, R. M., Nishimura, S., Imamura, Y., Kitayama, H., Alexander, D. B., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00597-9 · Cited by 728
Yu, Q., & Stamenkovic, I. (1999) · Genes & Development · doi:10.1101/gad.13.1.35 · Cited by 713
Bourboulia, D., & Stetler-Stevenson, W. G. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.05.002 · Cited by 710
Understanding resistance to EGFR inhibitors—impact on future treatment strategies
Wheeler, D. L., Dunn, E. F., & Harari, P. M. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.97 · Cited by 683
Van den Steen, P. E., Proost, P., Wuyts, A., Van Damme, J., & Opdenakker, G. (2000) · Blood · doi:10.1182/blood.v96.8.2673 · Cited by 680
Gelatinase-mediated migration and invasion of cancer cells
Björklund, M., & Koivunen, E. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.03.001 · Cited by 661
Brooks, P. C., Silletti, S., von Schalscha, T. L., Friedlander, M., & Cheresh, D. A. (1998) · Cell · doi:10.1016/s0092-8674(00)80931-9 · Cited by 623
Rodríguez, D., Morrison, C. J., & Overall, C. M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.09.015 · Cited by 560
Hamano, Y., Zeisberg, M., Sugimoto, H., Lively, J. C., Maeshima, Y., Yang, C., Hynes, R. O., Werb, Z., Sudhakar, A., & Kalluri, R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00133-8 · Cited by 559
Takahashi, C., Sheng, Z., Horan, T. P., Kitayama, H., Maki, M., Hitomi, K., Kitaura, Y., Takai, S., Sasahara, R. M., Horimoto, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13221 · Cited by 492
Xu, J., Rodriguez, D., Petitclerc, E., Kim, J. J., Hangai, M., Yuen, S. M., Davis, G. E., & Brooks, P. C. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200103111 · Cited by 489
IFN-γ Suppresses IL-10 Production and Synergizes with TLR2 by Regulating GSK3 and CREB/AP-1 Proteins
Hu, X., Paik, P. K., Chen, J., Yarilina, A., Kockeritz, L., Lu, T. T., Woodgett, J. R., & Ivashkiv, L. B. (2006) · Immunity · doi:10.1016/j.immuni.2006.02.014 · Cited by 406
A cancer cell metalloprotease triad regulates the basement membrane transmigration program
Hotary, K., Li, X.-Y., Allen, E., Stevens, S. L., & Weiss, S. J. (2006) · Genes & Development · doi:10.1101/gad.1451806 · Cited by 381
Cauwe, B., Van den Steen, P. E., & Opdenakker, G. (2007) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230701340019 · Cited by 381
The FERM domain: organizing the structure and function of FAK
Frame, M. C., Patel, H., Serrels, B., Lietha, D., & Eck, M. J. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2996 · Cited by 370
Levi, E., Fridman, R., Miao, H. Q., Ma, Y. S., Yayon, A., & Vlodavsky, I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7069 · Cited by 351
The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia
Klein, G., Vellenga, E., Fraaije, M. W., Kamps, W. A., & de Bont, E. S. J. M. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2003.09.001 · Cited by 350
Towards third generation matrix metalloproteinase inhibitors for cancer therapy
Overall, C. M., & Kleifeld, O. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603043 · Cited by 340
Rolli, M., Fransvea, E., Pilch, J., Saven, A., & Felding-Habermann, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633689100 · Cited by 332
The other side of MMPs: Protective roles in tumor progression
Martin, M. D., & Matrisian, L. M. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9089-4 · Cited by 311
Yang, Z., Strickland, D. K., & Bornstein, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008925200 · Cited by 297
Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers
Turpeenniemi-Hujanen, T. (2005) · Biochimie · doi:10.1016/j.biochi.2005.01.014 · Cited by 289
Bourguignon, L. Y. W., Gunja-Smith, Z., Iida, N., Zhu, H. B., Young, L. J. T., Muller, W. J., & Cardiff, R. D. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199807)176:1<206::aid-jcp22>3.0.co;2-3 · Cited by 270
A novel role of metalloproteinase in cancer-mediated immunosuppression.
Sheu, B., Hsu, S.-M., Ho, H., Lien, H., Huang, S., & Lin, R. H. (2001) · PubMed · Cited by 268
Silletti, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011343298 · Cited by 262
Transforming growth factor-β and the hallmarks of cancer
Tian, M., Neil, J. R., & Schiemann, W. P. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2010.10.015 · Cited by 244
Deryugina, E. I., & Quigley, J. P. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.09.017 · Cited by 238
Hahn-Dantona, E., Ruiz, J. F., Bornstein, P., & Strickland, D. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100121200 · Cited by 222
Heljasvaara, R., Nyberg, P., Luostarinen, J., Parikka, M., Heikkilä, P., Rehn, M., Sorsa, T., Salo, T., & Pihlajaniemi, T. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.03.021 · Cited by 217
Dumin, J. A., Dickeson, S. K., Stricker, T. P., Bhattacharyya-Pakrasi, M., Roby, J. D., Santoro, S. A., & Parks, W. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104179200 · Cited by 213
Fiore, E., Fusco, C., Romero, P., & Stamenkovic, I. (2002) · Oncogene · doi:10.1038/sj.onc.1205684 · Cited by 212
MMP‐2 alters VEGF expression via αVβ3 integrin‐mediated PI3K/AKT signaling in A549 lung cancer cells
Chetty, C., Lakka, S. S., Bhoopathi, P., & Rao, J. S. (2010) · International Journal of Cancer · doi:10.1002/ijc.25134 · Cited by 205
Van den Steen, P. E., Van Aelst, I., Hvidberg, V., Piccard, H., Fiten, P., Jacobsen, C., Moestrup, S. K., Fry, S., Royle, L., Wormald, M. R., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512308200 · Cited by 189
An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma
Takafuji, V, Forgues, M., Unsworth, E., Goldsmith, P., & Wang, X. W. (2007) · Oncogene · doi:10.1038/sj.onc.1210463 · Cited by 178
Dormán, G., Cseh, S., Hajdú, I., Barna, L., Kónya, D., Kupai, K., Kovács, L., & Ferdinandy, P. (2010) · Drugs · doi:10.2165/11318390-000000000-00000 · Cited by 178
Role of matrix metalloproteinases in melanoma cell invasion
Hofmann, U. B., Houben, R., Bröcker, E.-B., & Becker, J. C. (2005) · Biochimie · doi:10.1016/j.biochi.2005.01.013 · Cited by 176
Stefanidakis, M., & Koivunen, E. (2006) · Blood · doi:10.1182/blood-2006-02-005363 · Cited by 175
Redondo-Muñóz, J., Ugarte-Berzal, E., Terol, M. J., den Steen, P. E. V., del Cerro, M. H., Roderfeld, M., Roeb, E., Opdenakker, G., Garcia-Marco, J. A., & Garcı́a-Pardo, A. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.044 · Cited by 167
Mantuano, E., Inoue, G., Li, X., Takahashi, K., Gaultier, A., Gonias, S. L., & Campana, W. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3053-08.2008 · Cited by 167
Ardi, V. C., den Steen, P. E. V., Opdenakker, G., Schweighofer, B., Deryugina, E. I., & Quigley, J. P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033472 · Cited by 161
Cleavage of metastasis suppressor gene product KiSS-1 protein/metastin by matrix metalloproteinases
Takino, T., Koshikawa, N., Miyamori, H., Tanaka, M., Sasaki, T., Okada, Y., Seiki, M., & Sato, H. (2003) · Oncogene · doi:10.1038/sj.onc.1206542 · Cited by 160
Sela-Passwell, N., Rosenblum, G., Shoham, T., & Sagi, I. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.04.010 · Cited by 160
Role of the hemopexin domain of matrix metalloproteinases in cell migration
Dufour, A., Sampson, N. S., Zucker, S., & Cao, J. P. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21535 · Cited by 159
Cianfrocca, M. E., Cooley, T. P., Lee, J., Rudek, M. A., Scadden, D. T., Ratner, L., Pluda, J. M., Figg, W. D., Krown, S. E., & Dezube, B. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.153 · Cited by 156
Cell surface association of matrix metalloproteinase-9 (gelatinase B)
Fridman, R. A., Tóth, M., Chvyrkova, I., Meroueh, S. O., & Mobashery, S. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023091214123 · Cited by 155
Redondo-Muñóz, J., Ugarte-Berzal, E., Garcia-Marco, J. A., del Cerro, M. H., den Steen, P. E. V., Opdenakker, G., Terol, M. J., & García-Pardo, A. (2008) · Blood · doi:10.1182/blood-2007-08-109249 · Cited by 155
Bannikov, G. A., Karelina, T. V., Collier, I. E., Marmer, B. L., & Goldberg, G. I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110931200 · Cited by 154
Secreted Versus Membrane-anchored Collagenases
Sabeh, F., Li, X.-Y., Saunders, T. L., Rowe, R. G., & Weiss, S. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.002808 · Cited by 152
Role of Matrix Metalloproteinase-9 Dimers in Cell Migration
Dufour, A., Zucker, S., Sampson, N. S., Kuscu, C., & Cao, J. P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.091769 · Cited by 147
The Role of Tissue Inhibitors of Metalloproteinases in Tumorigenesis and Metastasis
Cruz‐Muñoz, W., & Khokha, R. (2008) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360801973244 · Cited by 137
Hangai, M., Kitaya, N., Xu, J., Chan, C. K.-C., Kim, J., Werb, Z., Ryan, S. J., & Brooks, P. C. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64418-5 · Cited by 132
Hofmann, U. B., Westphal, J. R., van Kraats, A. A., Ruiter, D. J., & van Muijen, G. N. P. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000701)87:1<12::aid-ijc3>3.0.co;2-a · Cited by 132
Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trials
Falardeau, P., Champagne, P., Poyet, P., Hariton, C., & Dupont, �. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90035-1 · Cited by 123
Monferran, S., Paupert, J., Dauvillier, S., Salles, B., & Muller, C. (2004) · EMBO Journal · doi:10.1038/sj.emboj.7600403 · Cited by 108
Biological activity and clinical implications of the matrix metalloproteinases.
Rydlová, M., Holubec, L., Ludvíková, M., Kalfeřt, D., Franekova, J., Povýsil, C., & Ludvíková, M. (2008) · PubMed · Cited by 107
Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons
Bauvois, B., Dumont, J., Mathiot, C., & Kolb, J. P. (2002) · Leukemia · doi:10.1038/sj.leu.2402472 · Cited by 106
Self-citationMatrix metalloproteinases as master regulators of the vicious cycle of bone metastasis
Lynch, C. C. (2010) · Bone · doi:10.1016/j.bone.2010.06.007 · Cited by 103
Gelatinase B/matrix metalloproteinase‐9 cleaves interferon‐β and is a target for immunotherapy
Nelissen, I., Martens, E., den Steen, P. E. V., Proost, P., Ronsse, I., & Opdenakker, G. (2003) · Brain · doi:10.1093/brain/awg129 · Cited by 100
Tóth, M., Gervasi, D. C., & Fridman, R. A. (1997) · PubMed · Cited by 91
A Catalytic Role for Proangiogenic Marrow-Derived Cells in Tumor Neovascularization
Seandel, M., Butler, J. M., Lyden, D. C., & Rafii, S. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.016 · Cited by 86
Selective Matrix Metalloproteinase Inhibitors for Cancer
Li, N., Shi, Z., Tang, Y., & Duan, J. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709789178037 · Cited by 85
Björklund, M., Heikkilä, P., & Koivunen, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401601200 · Cited by 81
Devy, L., & Dransfield, D. T. (2010) · Biochemistry Research International · doi:10.1155/2011/191670 · Cited by 78
Chiappori, A., Eckhardt, S., Bukowski, R. M., Sullivan, D. M., Ikeda, M., Yano, Y., Yamada‐Sawada, T., Kambayashi, Y., Tanaka, K., Javle, M. M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1586 · Cited by 70
Levkau, B., Kenagy, R. D., Karsan, A., Weitkamp, B., Clowes, A. W., Ross, R., & Raines, E. W. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401106 · Cited by 70
Matrix Metalloproteinase 1 Interacts with Neuronal Integrins and Stimulates Dephosphorylation of Akt
Conant, K. E., Hillaire, C. S., Nagase, H., Visse, R., Gary, D. S., Haughey, N. J., Anderson, C. F., Turchan-Cholewo, J. T., & Nath, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307051200 · Cited by 69
Nisato, R. E., Hossein, G., Sirrenberg, C., Butler, G. S., Crabbe, T., Docherty, A., Wiesner, M., Murphy, G., Overall, C. M., Goodman, S. L., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1512 · Cited by 68
Geurts, N., Martens, E., Aelst, I. V., Proost, P., Opdenakker, G., & den Steen, P. E. V. (2008) · Biochemistry · doi:10.1021/bi702260q · Cited by 67
Stefanidakis, M., Björklund, M., Ihanus, E., Gahmberg, C. G., & Koivunen, E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302288200 · Cited by 65
Hu, Y., & Ivashkiv, L. B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.6022 · Cited by 61
Stefanidakis, M., Ruohtula, T., Borregaard, N., Gahmberg, C. G., & Koivunen, E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.7060 · Cited by 60
Mauch, S., Kolb, C., Kolb, B., Sadowski, T., & Sedlacek, R. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1244 · Cited by 59
Yu, X., & Han, Z. (2006) · PubMed · doi:10.14670/hh-21.519 · Cited by 58
Inflammation and survival pathways: Chronic lymphocytic leukemia as a model system
Chen, L. S., Balakrishnan, K., & Gandhi, V. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.039 · Cited by 55
Freise, C., Erben, U., Muche, M., Farndale, R. W., Zeitz, M., Somasundaram, R., & Ruehl, M. (2009) · Matrix Biology · doi:10.1016/j.matbio.2009.08.001 · Cited by 51
Rao, J. S., Bhoopathi, P., Chetty, C., Gujrati, M., & Lakka, S. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0380 · Cited by 50
MMPs Are IGFBP‐Degrading Proteinases: Implications for Cell Proliferation and Tissue Growth
Fowlkes, J. L., SERRA, D. M., Nagase, H., & Thrailkill, K. M. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07765.x · Cited by 49
Rupp, P. A., Visconti, R. P., Czirók, A., Cheresh, D. A., & Little, C. D. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-05-0480 · Cited by 49
Wang, X.-Q., Sun, P., & Paller, A. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302211200 · Cited by 47
Lacerna, L. V., & Hohneker, J. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.08.017 · Cited by 43
Bałuk, P., Raymond, W. W., Ator, E., Coussens, L. M., McDonald, D. M., & Caughey, G. H. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00404.2003 · Cited by 41
Recent Advances in Studies on Hydroxamates as Matrix Metalloproteinase Inhibitors: A Review
Yadav, R. K., Gupta, S. P., Sharma, P. K., et al. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795471329 · Cited by 32
Cited by
NRF2 and the Hallmarks of Cancer
Rojo de la Vega, M., Chapman, E., & Zhang, D. D. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.022 · Cited by 1,672
Matrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makers
Rempe, R. G., Hartz, A. M., & Bauer, B. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16655551 · Cited by 721
The Role of Inflammation in the Pathogenesis of Osteoarthritis
Chow, Y. Y., & Chin, K.-Y. (2020) · Mediators of Inflammation · doi:10.1155/2020/8293921 · Cited by 523
Engineered nanomedicines with enhanced tumor penetration
Ding, J., Chen, J., Gao, L., Jiang, Z., Zhang, Y., Li, M., Xiao, Q., Lee, S. S., & Chen, X. (2019) · Nano Today · doi:10.1016/j.nantod.2019.100800 · Cited by 420
Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
Haibe, Y., Kreidieh, M., El Hajj, H., Khalifeh, I., Mukherji, D., Temraz, S., & Shamseddine, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00221 · Cited by 396
Metadata
- Authors
- Bauvois, B.
- Venue
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 1825
- Issue
- 1
- Pages
- 29-36
- ISSN
- 0304-419X (ISSN-L)
- OpenAlex
- W2034038746
- Cited by
- 543
- References
- 104
- FWCI
- 13.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.